2nd Annual Pharmaceutical Market Access in Latin America

Dec. 10, 2013 - PRLog -- As emerging markets capture a great portion of the global pharmaceutical market, these countries tend to develop and adapt the regulation standards to align the high quality expectations of regulated markets in the U.S. Or EU, while ensuring their own needs of public health goals. An improving regulatory environment and high volume of foreign investment has made Latin America‘s pharma market one of the most desirable ones. To achieve better market  penetration, however the companies have to be prepared to understand and communicate the regulatory changes and challenges that come along with the process of development. In fact, assessment of the current HTA models together with pharmacoeconomics related to formulary access decision-making procedure represent ‚must have‘ knowledge in order to mitigate entry barriers for new medicines.

Do you know how to tailor your approach to local needs or how to avoid underestimation of challenges, risks and investment needs? Valuable contributions from the region speakers will provide you with the answers. Get your notebooks prepared for the second volume of LATAM market access webinar!

Speakers

Silvia Sfeir
Novartis, Brazil
Director of Corporate Affairs

Marcello Scattollini
Secretary of Health of Sao Paolo, Brazil
Director, Division of Health

Nicolas Vargas Zea
Pfizer, Colombia
HEOR Manager

María Inés Guaia
K&G South, Italy
Owner/ Pharma Regulatory Affairs Consultant

Attend the Web conference: http://pharma.kakushinwebinars.com/market-access-latin-am...